INS and diabetes mellitus: Compared with the Q1 reference group, the ORs of multi-vessel CAD in the Q2, Q3, and Q4 groups exhibited a consistent upward trend across the NGR, pre-DM, and DM non-insulin Rx subgroups, with a P for trend < 0.01 in each subgroup.